Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Status:
Active, not recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine if left atrial appendage closure with the
WATCHMAN FLX Device is a reasonable alternative to oral anticoagulation following
percutaneous catheter ablation for high risk patients with non-valvular atrial fibrillation.